| Literature DB >> 28114408 |
Giovana Anovazzi1,2, Marcell Costa de Medeiros1, Suzane Cristina Pigossi1,2, Livia Sertori Finoti1,2, Marcia Pinto Alves Mayer3, Carlos Rossa1, Raquel Mantuaneli Scarel-Caminaga2.
Abstract
Chronic periodontitis (CP) is an infectious inflammatory disease that affects tooth-supporting structures and in which dental plaque bacteria, immune mechanisms and genetic predisposition play important roles. Interleukin 4 (IL-4) is a key anti-inflammatory cytokine with relevant action in imbalances in inflamed periodontal tissue. Individuals carrying the TCI/CCI genotype (S-haplotype) of the IL-4 gene are 5 times more susceptible to CP, whereas the CTI/TTD genotype (P-haplotype) confers protection against CP. Compared with the S-haplotype, subjects with the P-haplotype produce higher levels of the IL-4 protein after non-surgical periodontal therapy. The present in vitro study aimed to investigate the functionality of IL-4 haplotypes in immune cells to obtain insight into the influence of these genetic variations in regulating immune responses to CP-associated bacteria. Peripheral blood was collected from 6 subjects carrying each haplotype, and their immune cells were challenged with periodontopathogens to compare responses of the different haplotypes with regard to gene expression, protein secretion and the immunophenotype of T helper responses. We found higher IL-4 mRNA and protein levels in the P-haplotype, which also presented higher levels of anti-inflammatory cytokines. In contrast, cells from S-haplotype subjects responded with higher levels of pro-inflammatory cytokines. S-haplotype individuals exhibited significantly greater polarization toward the Th1 phenotype, whereas the P-haplotype was associated with an attenuated response to periodontopathogens, with suggestive skewing toward Th2/M2 phenotypes. In conclusion, IL-4 genetic variations associated with susceptibility to or protection against chronic periodontitis are directly associated with influencing the response of immune cells to periodontopathogens.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28114408 PMCID: PMC5256924 DOI: 10.1371/journal.pone.0169870
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Demographic profile and periodontal variables of the patients enrolled in the study.
| Haplotypes/Characteristics | CTI/TTD (N = 6) | TCI/CCI (N = 6) |
|---|---|---|
| 40 (36–45) | 39 (37–46) | |
| Female | 4 (90.0) | 4 (90.0) |
| Male | 2 (10.0) | 2 (10.0) |
| 28 (25–29) | 27 (25–28) | |
| 1.20 (0.99–1.31) | 1.27 (0.97–1.41) | |
| 1.26 (1.04–1.58) | 1.76 (1.21–2.25) | |
| 1.44(1.05–2.29) | 1.76(1.21–2.31) |
N = individuals number; % = percentage of the number of individuals; BOP = Bleeding on Probing; PPD = Periodontal Probing Depth; CAL = Clinical Attachment Level
Fig 1Gene expression (mRNA) levels of IL-4, IL-8, IL-12 and TNFA in isolated cells from the peripheral blood of subjects carrying susceptibility or protection haplotypes after Aa and Pg stimulation.
A. Neutrophils, B. monocytes, C. lymphocytes. The results are represented as the fold change (normalization to the endogenous control). *p < 0.05; ** p < 0.01; *** p < 0.001. The Mann-Whitney test.
Fig 2A. Inflammatory Panel B. Th1/Th2 Panel represented by the proteins analyzed by a multiplex assay in the whole blood of subjects carrying susceptibility or protection haplotypes after Aa and Pg stimulation. The concentration is expressed in pg/mL. *p < 0.05; ** p < 0.01; *** p < 0.001. The Mann-Whitney test.
Fig 3A. Cytokine II Panel, B. Chemokine II Panel represented by the proteins analyzed by a multiplex assay in the whole blood of subjects carrying susceptibility or protection haplotypes after Aa and Pg stimulation. The concentration is expressed in pg/mL. *p < 0.05; ** p < 0.01; *** p < 0.001. The Mann-Whitney test.
Fig 4Profiles assessed by flow cytometry in whole from of subjects with susceptibility or protection haplotypes after Aa and Pg stimulation.
A. Monocyte gate; B. dot-blot representative of M1 and M2; C. fold change of all subjects of the M1 profile; D. fold change of all subjects of the M2 profile; E. CD4+ gate; F. dot-blot representative of Th1 and Th2; G. fold change of all subjects of the Th1 profile; H. fold change of all subjects of the Th2 profile; I. CD4+ gate; J. dot-blot representative of Th17 and Treg; K. fold change of all subjects of the Th17 profile; L. fold change of all subjects of the Treg profile. *p < 0.05; ** p < 0.01. The Mann-Whitney test.